Pilot and Feasibility Program
Pilot and Feasibility Program
批准号:
10456261
负责人:
PAUL W. SANDERS
金额:
$15.03万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-01 至 2023-07-31
关键词:
Acute Renal Failure with Renal Papillary NecrosisAddressAreaAwardDataDevelopmentDoctor of PhilosophyExtramural ActivitiesExtramural Funding MechanismsFacultyFundingGoalsGrantInstitutionInvestmentsKidneyMissionPaperPeer ReviewPhysiciansPilot ProjectsProductivityPublishingResearchResearch PersonnelResearch ProposalsResearch SupportResourcesScientistSeedsStudy SectionTrainingcareer developmentfield studyinnovationinterestprogramsrecruitresearch and developmentresponsesuccess
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
The principal objective of the UAB-UCSD O'Brien Center Pilot and Feasibility (PAF) Grants Program is
to provide seed funds for new, outstanding, and innovative research proposals related to AKI. These pilot
funds will provide eligible investigators with one to two years of support along with the resources necessary to
explore investigator-initiated projects related to AKI.
The UAB-UCSD O'Brien Center PAF Program will have a tri-partite focus with a mission 1) to attract
junior faculty to AKI-related research; 2) enable established investigators in other fields to explore the feasibility
of new, innovative concepts in AKI-related research; and 3) entice investigators with research expertise in the
Core Center's thematic areas to apply their expertise to AKI-related questions. The PAF Program has been
successful in this mission. There is a high level of recurring interest, with an average of 19 applications/year in
response to our RFAs. All funded applications were judged to be highly meritorious by our study section, which
consists of our intramural experts. The Program has recruited 12 physician-scientists and 11 Ph.D. scientists,
including promising faculty from institutions outside UAB and UCSD. Eighteen of the 23 investigators funded
by this program were new to the AKI field, and about 83% have remained in kidney-related research. These
investigators have demonstrated significant productivity, including 39 peer-reviewed papers published by pilot
recipients funded during this cycle. At present, collectively the 23 recipients have a 66.7% success rate in
obtaining subsequent extramural funding. The UAB-UCSD O'Brien Center PAF Program will continue to
leverage institutional resources ($335,000 during the present cycle) at both UAB and UCSD, which will permit
an increase in the total investment for our Pilot Program recipients. Three to four awards per year will continue
to be supported by this program, with two supported by O'Brien Center funds and the additional 1-2 from
institutional funds.
The ultimate goal of the UAB-UCSD O'Brien Center PAF program is to provide sufficient resources and
training for pilot investigators to pursue research that advances the treatment of AKI.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pre-Clinical Core
-
批准号:10746570
-
项目类别:
-
资助金额:$25.2万
-
财政年份:2023
-
负责人:PAUL W. SANDERS
-
依托单位:
Vascular Mechanisms of Hypertensive Nephropathy
-
批准号:10533780
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:PAUL W. SANDERS
-
依托单位:
Vascular Mechanisms of Hypertensive Nephropathy
-
批准号:10363532
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:PAUL W. SANDERS
-
依托单位:
Low Molecular Weight Protein Nephrotoxicity
-
批准号:10041695
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:PAUL W. SANDERS
-
依托单位:
Low Molecular Weight Protein Nephrotoxicity
-
批准号:10578666
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:PAUL W. SANDERS
-
依托单位:
Low Molecular Weight Protein Nephrotoxicity
-
批准号:10295150
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:PAUL W. SANDERS
-
依托单位:
Low Molecular Weight Protein Nephrotoxicity
-
批准号:9778058
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:PAUL W. SANDERS
-
依托单位:
Low Molecular Weight Protein Nephrotoxicity
-
批准号:8696837
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:PAUL W. SANDERS
-
依托单位:
Low Molecular Weight Protein Nephrotoxicity
-
批准号:8277784
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:PAUL W. SANDERS
-
依托单位:
Low Molecular Weight Protein Nephrotoxicity
-
批准号:8398973
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:PAUL W. SANDERS
-
依托单位:
Low Molecular Weight Protein Nephrotoxicity
-
批准号:8140851
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:PAUL W. SANDERS
-
依托单位:
Mechanisms of Salt-Sensitive Hypertension and Hypertensive Nephrosclerosis
-
批准号:7903735
-
项目类别:
-
资助金额:$4.84万
-
财政年份:2009
-
负责人:PAUL W. SANDERS
-
依托单位:
Core B - Resource for Pre-Clinical Studies of AKI
-
批准号:10252038
-
项目类别:
-
资助金额:$25.44万
-
财政年份:2008
-
负责人:PAUL W. SANDERS
-
依托单位:
Pilot and Feasibility Program
-
批准号:10252040
-
项目类别:
-
资助金额:$15.03万
-
财政年份:2008
-
负责人:PAUL W. SANDERS
-
依托单位:
Core B - Resource for Pre-Clinical Studies of AKI
-
批准号:10456259
-
项目类别:
-
资助金额:$25.44万
-
财政年份:2008
-
负责人:PAUL W. SANDERS
-
依托单位:
Resource for Pre-Clinical Studies of AKI (Animal Models/lmaging/Renal Physiology
-
批准号:8733666
-
项目类别:
-
资助金额:$23.07万
-
财政年份:2008
-
负责人:PAUL W. SANDERS
-
依托单位:
Resource for Pre-Clinical Studies of AKI (Animal Models/lmaging/Renal Physiology
-
批准号:8625443
-
项目类别:
-
资助金额:$23.07万
-
财政年份:2008
-
负责人:PAUL W. SANDERS
-
依托单位:
Resource for Pre-Clinical Studies of AKI (Animal Models/lmaging/Renal Physiology
-
批准号:9124659
-
项目类别:
-
资助金额:$23.07万
-
财政年份:2008
-
负责人:PAUL W. SANDERS
-
依托单位:
Resource for Pre-Clinical Studies of AKI (Animal Models/lmaging/Renal Physiology
-
批准号:8899510
-
项目类别:
-
资助金额:$23.07万
-
财政年份:2008
-
负责人:PAUL W. SANDERS
-
依托单位:
NITRIC OXIDE AND HEREDITARY LOW RENIN HYPERTENSION
-
批准号:2145379
-
项目类别:
-
资助金额:$15.84万
-
财政年份:1992
-
负责人:PAUL W. SANDERS
-
依托单位:
海外基金